Drug maker Roche breaks into gene therapy with $4.3B deal to buy U.S.-based Spark
Monday, February 25, 2019 - 08:00
in Mathematics & Economics
Swiss pharmaceutical giant Roche Holding announced Monday it will acquire U.S.-based genetic therapy researcher Spark Therapeutics, for more than $4 billion.